Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) EBIT Margin (2021 - 2025)

Historic EBIT Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 23682.56%.

  • Pulse Biosciences' EBIT Margin changed N/A to 23682.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 91798.84%, marking a year-over-year change of. This contributed to the annual value of 8293.86% for FY2022, which is 38499900.0% down from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' EBIT Margin is 23682.56%.
  • In the past 5 years, Pulse Biosciences' EBIT Margin registered a high of 97166.67% during Q4 2022, and its lowest value of 23682.56% during Q3 2025.
  • For the 3-year period, Pulse Biosciences' EBIT Margin averaged around 10101.67%, with its median value being 3188.45% (2022).
  • Data for Pulse Biosciences' EBIT Margin shows a peak YoY increase of 989925000bps (in 2022) and a maximum YoY decrease of 989925000bps (in 2022) over the last 5 years.
  • Over the past 3 years, Pulse Biosciences' EBIT Margin (Quarter) stood at 1825.83% in 2021, then skyrocketed by 5422bps to 97166.67% in 2022, then tumbled by -124bps to 23682.56% in 2025.
  • Its EBIT Margin stands at 23682.56% for Q3 2025, versus 97166.67% for Q4 2022 and 4671.33% for Q2 2022.